Yayın:
Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKırımlıoğlu, Gülsel Yurtdaş
dc.contributor.authorGüleç, Kadri
dc.contributor.authorGörgülü, Şennur
dc.contributor.authorKIYAN, HÜLYA TUBA
dc.contributor.orcid0000-0001-8897-0885
dc.contributor.orcid0000-0002-1392-8276
dc.contributor.orcid0000-0003-2026-2924
dc.contributor.orcid0000-0001-5304-868X
dc.date.accessioned2025-11-13T10:15:14Z
dc.date.issued2021-09-11
dc.identifier.doihttps://doi.org/10.1016/j.mvr.2021.104251
dc.identifier.endpage104251
dc.identifier.issn0026-2862
dc.identifier.openalexW3199294400
dc.identifier.startpage104251
dc.identifier.urihttps://hdl.handle.net/11421/3590
dc.identifier.urihttps://doi.org/10.1016/j.mvr.2021.104251
dc.identifier.volume139
dc.language.isoen
dc.relation.ispartofMicrovascular Research
dc.rightsrestrictedAccess
dc.subjectIn vivo
dc.subjectApoptosis
dc.subjectCytotoxicity
dc.subjectChemistry
dc.subjectAnnexin
dc.subjectBiophysics
dc.subjectPharmacology
dc.subjectIn vitro
dc.subjectBiochemistry
dc.subjectBiology
dc.subject.sdg3
dc.titleOseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5030894826
local.authorid.openalexA5015589520
local.authorid.openalexA5080219288
local.authorid.openalexA5083635559

Dosyalar

Koleksiyonlar

Publications